Computational analysis of Piper spp.-derived natural products as anti-cancer potential through targeting aurora kinase A
References
- K. Polyak, Heterogeneity in breast cancer, The Journal of Clinical Investigation 121 (2011) 3786–3788. Doi: 10.1172/JCI60534
- Q. Zhou, C. Tao, J. Yuan, F. Pan, R. Wang, Knowledge mapping of AURKA in oncology: An advanced bibliometric analysis (1998–2023), Heliyon 10 (2024) e31945. Doi: 10.1016/j.heliyon.2024.e31945
- K. Nikhil, K. Shah, The significant others of aurora kinase A in cancer: combination is the key, Biomarker Research 12 (2024) 109. Doi: 10.1186/s40364-024-00651-4
- M. Chen, H. Zhu, J. Li, D. Luo, J. Zhang, W. Liu, J. Wang, Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA, Annals of Medicine 56 (2024) 2282184. Doi: 10.1080/07853890.2023.2282184
- R. Du, C. Huang, K. Liu, X. Li, Z. Dong, Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy, Molecular Cancer 20 (2021) 15. Doi: 10.1186/s12943-020-01305-3
- S. Chung, E. Sperier, K. Graciano, X. Hu, H. Guo, J. Xu, Aurora kinases, emerging critical targets for cancer treatment and related new therapeutic strategies, Bioorganic Chemistry 163 (2025) 108633. Doi: 10.1016/j.bioorg.2025.108633
- O. Gautschi, P.C. Mack, A.M. Davies, P.N. Lara, D.R. Gandara, Aurora kinase inhibitors: A new class of targeted drugs in cancer, Clinical Lung Cancer 8 (2006) 93–98. Doi: 10.3816/CLC.2006.n.036
- G.M. Cragg, J.M. Pezzuto, Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents, Medical Principles and Practice 25 (2016) 41–59. Doi: 10.1159/000443404
- C.F. Stratton, D.J. Newman, D.S. Tan, Cheminformatic comparison of approved drugs from natural product versus synthetic origins, Bioorganic & Medicinal Chemistry Letters 25 (2015) 4802–4807. Doi: 10.1016/j.bmcl.2015.07.014
- G. Nuzzo, G. Senese, C. Gallo, F. Albiani, L. Romano, G. d’Ippolito, E. Manzo, A. Fontana, Antitumor potential of immunomodulatory natural products, Marine Drugs 20 (2022) 386. Doi: 10.3390/md20060386
- J.L. Huo, W.J. Fu, Z.H. Liu, N. Lu, X.Q. Jia, Z.S. Liu, Research advance of natural products in tumor immunotherapy, Frontiers in Immunology 13 (2022) 972345. Doi: 10.3389/fimmu.2022.972345
- A. Naeem, P. Hu, M. Yang, J. Zhang, Y. Liu, W. Zhu, Q. Zheng, Natural products as anticancer agents: Current status and future perspectives, Molecules 27 (2022) 8367. Doi: 10.3390/molecules27238367
- B. Salehi, Z.A. Zakaria, R. Gyawali, S.A. Ibrahim, J. Rajkovic, Z.K. Shinwari, T. Khan, J. Sharifi-Rad, A. Ozleyen, E. Turkdonmez, M. Valussi, T.B. Tumer, L. Monzote Fidalgo, M. Martorell, W.N. Setzer, Piper species: A comprehensive review on their phytochemistry, biological activities and applications, Molecules 24 (2019) 1364. Doi: 10.3390/molecules24071364
- C.K. Woon, F.B. Ahmad, N.H. Zamakshshari, Chemical constituents and biological activities of Piper as anticancer agents: A review, Chemistry & Biodiversity 20 (2023) e202300166. Doi: 10.1002/cbdv.202300166
- J. Wang, K. Nikhil, K. Viccaro, L. Chang, J. White, K. Shah, Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: Insights on their synergistic relationship in pancreatic cancer, BMC Biology 15 (2017) 10. Doi: 10.1186/s12915-016-0335-5
- V.R. Umapathy, A. Dhanavel, R. Kesavan, P.M. Natarajan, S.B., P.V., Anticancer potential of the principal constituent of Piper nigrum, piperine: A comprehensive review, Cureus 16 (2024) e54425. Doi: 10.7759/cureus.54425
- H.W. Jo, M.M. Kim, β-Caryophyllene oxide inhibits metastasis by downregulating MMP-2, pp38 and p-ERK in human fibrosarcoma cells, Journal of Food Biochemistry 46 (2022) e14468. Doi: 10.1111/jfbc.14468
- Q.H. Nguyen, T.T. Nguyen, V. Truong, C.T.T. Do, H.T. Tran, S.K. Nguyen, P.H. Nguyen, T.H. Nguyen, N.D. Le, D.T. Nguyen, T.P.T. Nguyen, V.P. Nguyen, T.A. Nguyen, O. Koshovyi, A. Raal, New insights into the chemical composition of Piper spp. collected in the northern region of Vietnam, Biochemical Systematics and Ecology 112 (2023) 104770. Doi: 10.1016/j.bse.2023.104770
- A. Daina, O. Michielin, V. Zoete, SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Scientific Reports 7 (2017) 42717. Doi: 10.1038/srep42717
- P. Banerjee, E. Kemmler, M. Dunkel, R. Preissner, ProTox 3.0: A webserver for the prediction of toxicity of chemicals, Nucleic Acids Research 52 (2024) W513–W520. Doi: 10.1093/nar/gkae303
- A. Daina, O. Michielin, V. Zoete, SwissTargetPrediction: Updated data and new features for efficient prediction of protein targets of small molecules, Nucleic Acids Research 47 (2019) W357–W364. Doi: 10.1093/nar/gkz382
- D. Szklarczyk, R. Kirsch, M. Koutrouli, K. Nastou, F. Mehryary, R. Hachilif, A.L. Gable, T. Fang, N.T. Doncheva, S. Pyysalo, P. Bork, L.J. Jensen, C. von Mering, The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest, Nucleic Acids Research 51 (2023) D638–D646. Doi: 10.1093/nar/gkac1000
- O. Menyhart, W.J. Kothalawala, B. Gyorffy, A gene set enrichment analysis for the cancer hallmarks, Journal of Pharmaceutical Analysis 15 (2024) 101065. Doi: 10.1016/j.jpha.2024.101065
- D.S. Chandrashekar, S.K. Karthikeyan, P.K. Korla, H. Patel, A.R. Shovon, M. Athar, G.J. Netto, Z.S. Qin, S. Kumar, U. Manne, C.J. Creighton, S. Varambally, UALCAN: An update to the integrated cancer data analysis platform, Neoplasia 25 (2022) 18–27. Doi: 10.1016/j.neo.2022.01.001
- Z. Tang, C. Li, B. Kang, G. Gao, C. Li, Z. Zhang, GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses, Nucleic Acids Research 45 (2017) W98–W102. Doi: 10.1093/nar/gkx247
- T. Li, J. Fan, B. Wang, N. Traugh, Q. Chen, J.S. Liu, B. Li, X.S. Liu, TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells, Cancer Research 77 (2017) e108–e110. Doi: 10.1158/0008-5472.CAN-17-0307
- H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne, The Protein Data Bank, Nucleic Acids Research 28 (2000) 235–242. Doi: 10.1093/nar/28.1.235
- M. Wiederstein, M.J. Sippl, ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins, Nucleic Acids Research 35 (2007) W407–W410. Doi: 10.1093/nar/gkm290
- S. Kim, J. Chen, T. Cheng, A. Gindulyte, J. He, S. He, Q. Li, B.A. Shoemaker, P.A. Thiessen, B. Yu, L. Zaslavsky, J. Zhang, E.E. Bolton, PubChem 2023 update, Nucleic Acids Research 51 (2023) D1373–D1380. Doi: 10.1093/nar/gkac956
- G. Tang, W. Wang, C. Zhu, H. Huang, P. Chen, X. Wang, M. Xu, J. Sun, C.J. Zhang, Q. Xiao, L. Gao, Z.M. Zhang, S.Q. Yao, Global reactivity profiling of the catalytic lysine in human kinome for covalent inhibitor development, Angewandte Chemie International Edition 63 (2024) e202316394. Doi: 10.1002/anie.202316394
- S. Dallakyan, A.J. Olson, Small-molecule library screening by docking with PyRx, Methods in Molecular Biology 1263 (2015) 243–250. Doi: 10.1007/978-1-4939-2269-7_19
- K. Ozvoldik, T. Stockner, E. Krieger, YASARA Model-Interactive molecular modeling from two dimensions to virtual realities, Journal of Chemical Information and Modeling 63 (2023) 6177–6182. Doi: 10.1021/acs.jcim.3c01136
- W. Pitsawong, V. Buosi, R. Otten, R.V. Agafonov, A. Zorba, N. Kern, S. Kutter, G. Kern, R.A. Pádua, X. Meniche, D. Kern, Dynamics of human protein kinase Aurora A linked to drug selectivity, eLife 7 (2018) e36656. Doi: 10.7554/eLife.36656
- A. Goyal, S. Gupta, Y. Gupta, N. Tandon, Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings, Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (2020) 753–756. Doi: 10.1016/j.dsx.2020.05.039
- E.O. Johnson, K.-H. Chang, Y. de Pablo, S. Ghosh, R. Mehta, S. Badve, K. Shah, PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer, Journal of Cell Science 124 (2011) 2711–2722. Doi: 10.1242/jcs.084970
- Y.H. Wang, S.L. Morris-Natschke, J. Yang, H.M. Niu, C.L. Long, K.H. Lee, Anticancer principles from medicinal piper (hú jiāo) plants, Journal of Traditional and Complementary Medicine 4 (2014) 8–16. Doi: 10.4103/2225-4110.124811
- N. Varshney, R.K. Pandey, A. Mishra, S. Kumar, H.C. Jha, Aurora kinase A: Integrating insights into cancer, inflammation, and infectious diseases, Gut Microbes Reports 1 (2024) 2419069. Doi: 10.1080/29933935.2024.2419069
- E. Willems, M. Dedobbeleer, M. Digregorio, A. Lombard, P.N. Lumapat, B. Rogister, The functional diversity of Aurora kinases: A comprehensive review, Cell Division 13 (2018) 7. Doi: 10.1186/s13008-018-0040-6
- C. Arter, L. Trask, S. Ward, S. Yeoh, R. Bayliss, Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors, The Journal of Biological Chemistry 298 (2022) 102247. Doi: 10.1016/j.jbc.2022.102247
- G.M.T. Cheetham, R.M.A. Knegtel, J.T. Coll, S.B. Renwick, L. Swenson, P. Weber, J.A. Lippke, D.A. Austen, Crystal structure of Aurora-2, an oncogenic serine/threonine kinase, Journal of Biological Chemistry 277 (2002) 42419–42422. Doi: 10.1074/jbc.C200426200
- E.F. Ruff, J.M. Muretta, A.R. Thompson, E.W. Lake, S. Cyphers, S.K. Albanese, S.M. Hanson, J.M. Behr, D.D. Thomas, J.D. Chodera, N.M. Levinson, A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation, eLife 7 (2018) e32766. Doi: 10.7554/eLife.32766
Language: English
Page range: 1 - 14
Submitted on: Nov 28, 2025
Accepted on: Mar 13, 2026
Published on: May 25, 2026
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Wira Eka Putra, Diana Widiastuti, Arief Hidayatullah, Hary Isnanto, Muhammad Fikri Heikal, Sustiprijatno Sustiprijatno, Dewi Ratih Tirto Sari, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.